Zymeworks Inc
ZYME22.720USD
+0.700+3.18%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
1.72B시가총액
손실P/E TTM
자세한 내용은 Zymeworks Inc 회사
Zymeworks Inc. is a global clinical-stage biotechnology company. The Company is developing a diverse pipeline of multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases such as cancer, autoimmune and inflammatory diseases (AIID). The Company engineered and developed zanidatamab, a HER2-targeted bispecific antibody using the Company’s Azymetric technology. It has entered into separate agreements with BeiGene, Ltd. and Jazz Pharmaceuticals Ireland Limited, granting each exclusive rights to develop and commercialize zanidatamab in different territories. It is advancing a pipeline of wholly-owned product candidates, leveraging its expertise in both antibody-drug conjugates and multispecific antibody therapeutics targeting novel pathways in areas of significant unmet medical need. The Company has two clinical-stage product candidates: ZW171 and ZW191. Its preclinical product candidates include ZW251, ZW220, ZW209, and ZW1528.
Zymeworks Inc 정보
종목 코드 ZYME
회사 이름Zymeworks Inc
상장일Jun 24, 2019
CEOGalbraith (Kenneth H)
직원 수280
유형Ordinary Share
회계 연도 종료Jun 24
주소108 Patriot Drive, Suite A
도시MIDDLETOWN
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호19709
전화13022748744
웹사이트https://www.zymeworks.com/
종목 코드 ZYME
상장일Jun 24, 2019
CEOGalbraith (Kenneth H)
Zymeworks Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Paul A. Moore, Ph.D.
Dr. Paul A. Moore, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Carlos E. Campoy
Mr. Carlos E. Campoy
Independent Director
Independent Director
--
--
Dr. Alessandra Cesano, M.D., Ph.D.
Dr. Alessandra Cesano, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Scott Platshon
Mr. Scott Platshon
Acting Chief Investment Officer
Acting Chief Investment Officer
--
--
Ms. Leone D. Patterson, CPA
Ms. Leone D. Patterson, CPA
Chief Financial Officer, Chief Business Officer, Executive Vice President
Chief Financial Officer, Chief Business Officer, Executive Vice President
--
--
Dr. Jeffrey Smith, M.D.
Dr. Jeffrey Smith, M.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
--
Mr. Oleg Nodelman
Mr. Oleg Nodelman
Independent Director
Independent Director
--
--
Mr. Gregory A. Ciongoli
Mr. Gregory A. Ciongoli
Independent Director
Independent Director
--
--
Mr. Robert E. (Bob) Landry
Mr. Robert E. (Bob) Landry
Independent Director
Independent Director
--
--
Mr. Kenneth H. (Ken) Galbraith
Mr. Kenneth H. (Ken) Galbraith
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Paul A. Moore, Ph.D.
Dr. Paul A. Moore, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Carlos E. Campoy
Mr. Carlos E. Campoy
Independent Director
Independent Director
--
--
Dr. Alessandra Cesano, M.D., Ph.D.
Dr. Alessandra Cesano, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Scott Platshon
Mr. Scott Platshon
Acting Chief Investment Officer
Acting Chief Investment Officer
--
--
Ms. Leone D. Patterson, CPA
Ms. Leone D. Patterson, CPA
Chief Financial Officer, Chief Business Officer, Executive Vice President
Chief Financial Officer, Chief Business Officer, Executive Vice President
--
--
Dr. Jeffrey Smith, M.D.
Dr. Jeffrey Smith, M.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
--
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Sun, Feb 1
마지막 업데이트: Sun, Feb 1
주주
주주 유형
주주
주주
비율
EcoR1 Capital, LLC
30.69%
Rubric Capital Management LP
6.29%
BVF Partners L.P.
5.26%
Morgan Stanley & Co. LLC
5.23%
Redmile Group, LLC
4.95%
기타
47.56%
주주
주주
비율
EcoR1 Capital, LLC
30.69%
Rubric Capital Management LP
6.29%
BVF Partners L.P.
5.26%
Morgan Stanley & Co. LLC
5.23%
Redmile Group, LLC
4.95%
기타
47.56%
주주 유형
주주
비율
Investment Advisor/Hedge Fund
51.31%
Investment Advisor
20.98%
Hedge Fund
18.80%
Research Firm
6.53%
Private Equity
2.79%
Individual Investor
1.24%
Venture Capital
0.28%
Sovereign Wealth Fund
0.27%
Pension Fund
0.25%
기관 주식 보유
마지막 업데이트: Wed, Jan 21
마지막 업데이트: Wed, Jan 21
보고 기간
기관 수
보유 주식
비율
변동
2026Q4
333
74.80M
105.96%
--
2025Q4
404
76.14M
101.75%
-5.97M
2025Q3
390
74.41M
99.43%
-2.56M
2025Q2
383
76.90M
102.73%
+2.83M
2025Q1
400
71.70M
97.61%
-1.37M
2024Q4
389
68.69M
99.73%
-8.79M
2024Q3
388
74.13M
105.03%
-25.13M
2024Q2
387
74.77M
106.29%
-27.88M
2024Q1
389
74.54M
106.20%
-28.73M
2023Q4
388
72.09M
103.65%
-29.69M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
EcoR1 Capital, LLC
22.97M
30.69%
--
--
Nov 16, 2025
Rubric Capital Management LP
4.71M
6.29%
--
--
Sep 30, 2025
BVF Partners L.P.
3.94M
5.26%
-370.29K
-8.59%
Sep 30, 2025
Morgan Stanley & Co. LLC
3.92M
5.23%
+295.26K
+8.15%
Sep 30, 2025
Redmile Group, LLC
3.71M
4.95%
-444.88K
-10.72%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
3.12M
4.17%
+11.88K
+0.38%
Sep 30, 2025
The Vanguard Group, Inc.
2.15M
2.87%
-310.26K
-12.63%
Sep 30, 2025
Perceptive Advisors LLC
2.09M
2.79%
+815.39K
+63.94%
Sep 30, 2025
Vestal Point Capital, LP
1.76M
2.36%
+615.00K
+53.48%
Sep 30, 2025
Blackstone Alternative Asset Management, L.P.
1.62M
2.16%
-40.50K
-2.44%
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
Tema Oncology ETF
2.25%
Virtus LifeSci Biotech Clinical Trials ETF
0.99%
ProShares Ultra Nasdaq Biotechnology
0.24%
iShares Micro-Cap ETF
0.18%
Federated Hermes MDT Small Cap Core ETF
0.15%
WisdomTree US SmallCap Quality Growth Fund
0.15%
SPDR S&P International Small Cap ETF
0.14%
Invesco Nasdaq Biotechnology ETF
0.14%
iShares Biotechnology ETF
0.12%
iShares MSCI USA Small-Cap Min Vol Factor ETF
0.12%
더 보기
Tema Oncology ETF
비율2.25%
Virtus LifeSci Biotech Clinical Trials ETF
비율0.99%
ProShares Ultra Nasdaq Biotechnology
비율0.24%
iShares Micro-Cap ETF
비율0.18%
Federated Hermes MDT Small Cap Core ETF
비율0.15%
WisdomTree US SmallCap Quality Growth Fund
비율0.15%
SPDR S&P International Small Cap ETF
비율0.14%
Invesco Nasdaq Biotechnology ETF
비율0.14%
iShares Biotechnology ETF
비율0.12%
iShares MSCI USA Small-Cap Min Vol Factor ETF
비율0.12%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
